Reuters

Reuters

The Latest

  • Gilead's Shares Rise After $21 Billion Deal For Immunomedics
    Gilead Sciences
    Shares of Gilead Sciences Inc rose 3.2% on Monday, reversing their premarket losses as investors shrugged off concerns over the steep premium the U.S. drugmaker was willing to pay for Immunomedics Inc.
  • Exclusive: China Would Rather See TikTok U.S. Close Than A Forced Sale
    NOT SO FAST
    Beijing opposes a forced sale of TikTok's U.S. operations by its Chinese owner ByteDance, and would prefer to see the short video app shut down in the United States, three people with direct knowledge of the matter said on Friday.
  • Special Report: Big Pharma Wages Stealth War On Drug Price Watchdog
    Steven Pearson
    As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts' estimates that its maker, Gilead Sciences Inc, could charge up to $10,000 for the treatment.
  • The Extraterrestrial Truth Is Out There – We Just Can’t Find It
    Extraterrestrial life
    "It is not surprising that we didn't find something. There are still so many unknown variables," astrophysicist Chenoa Tremblay says.
  • China, India Cool Tense Border Standoff After High-Level Summit In Moscow
    China-India border stadoff
    China and India have agreed to de-escalate their contested Himalayan border and restore “peace."
  • Israeli Mask Maker Sonovia Awaits China Coronavirus Lab Result
    Israel's Sonovia Ltd's washable and reusable antiviral masks
    An Israeli company expects to receive results in the coming week from a Beijing lab that will test whether a fabric it has developed will be able to neutralise 99% of COVID-19, even after being washed multiple times.
  • AstraZeneca Pauses Coronavirus Vaccine Trial, Shares Slip On Rollout Doubts
    AstraZeneca China
    AstraZeneca has suspended global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, knocking the British drugmaker's shares on Wednesday as prospects for an early rollout dimmed.
  • U.S. Regulator Calls Climate Change A Systemic Risk
    FED
    A report found that climate change poses a "slow motion" threat to the U.S. financial system.
  • Wall Street Opens Higher After Three-day Selloff As Tech Stocks Stabilize
    Wall Street
    Wall Street's main indexes opened higher on Wednesday, as a rout in technology shares halted and investors shrugged off news that AstraZeneca had paused global trials of its experimental coronavirus vaccine.
  • 'Fist Bumps' Are Out As Malaysia's COVID Cases Climb
    Malaysia Covid-19
    Malaysia's top health official said any form of physical contact presents the risk of infection, including the now popular fist bumps.
1   2   3   4   5   6   7   8   9   10  Next